Back to Search
Start Over
Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
- Source :
-
The New England journal of medicine [N Engl J Med] 2024 Jul 11; Vol. 391 (2), pp. 185-186. - Publication Year :
- 2024
- Subjects :
- Humans
Male
Chemotherapy, Adjuvant
Nephrectomy
Clinical Trials as Topic
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Monoclonal, Humanized adverse effects
Antineoplastic Agents, Immunological therapeutic use
Antineoplastic Agents, Immunological adverse effects
Carcinoma, Renal Cell drug therapy
Carcinoma, Renal Cell mortality
Kidney Neoplasms drug therapy
Kidney Neoplasms mortality
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4406
- Volume :
- 391
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The New England journal of medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38986065
- Full Text :
- https://doi.org/10.1056/NEJMc2406031